Skip to content
CleanVoiceWorld

The Zimbabwean Government Rejects ‘One-Sided’ American Healthcare Assistance Deal Due to Information Apprehensions

Health aid illustration
The offered US funding would have supported programmes for HIV/Aids treatment and prevention, TB, and malarial diseases.

The nation of Zimbabwe has rejected a significant US health deal worth 367 million US dollars (£272m) spanning five years because of the United States' insistence on sensitive data.

The decision came to light following a government memo from December was leaked, indicating that Head of State Emmerson Mnangagwa deemed the arrangement was "unbalanced".

A government spokesperson has since stated that the United States was demanding access to biological samples for research and profit while refused to guarantee the benefits from future medical innovations.

"We will now turn to the challenging and unfortunate process of ending our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy noted the United States had provided more than $1.9bn for health programmes to Zimbabwe during the past twenty years.

A medical body in Zimbabwe has urged further talks to secure a deal agreeable to both sides so the nation's vital HIV programme can proceed.

Wider Context

This development comes after a similar case in Kenya, where a high court blocked a related health funding agreement after concerns were filed about the security of citizens' health data.

Since returning to the presidency recently, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).

The agency had administered assistance for the American government, but Trump stated its spending was "wasteful" and his administration was seeking direct bilateral agreements to enhance transparency and accountability.

According to reports, Sixteen nations in Africa have so far signed these new agreements, constituting more than $18.3bn in committed funds.

Details of the Declined Agreement

The funds for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.

"We are confident this cooperation would have delivered significant benefits for the people of Zimbabwe, especially the 1.2 million presently receiving antiretroviral therapy through US-supported initiatives," the Ambassador said.

However, official spokesman Nick Mangwana maintained the proposed deal was "unequal".

"The proposal required Zimbabwe to provide its biological resources and data for a long time, with no equivalent assurance of benefiting from any medical innovations – such as new medicines or tests – that could be developed from that shared data," he stated.

"Effectively, our nation would provide the raw materials for medical research with no assurance that the end products would be available to our citizens if a future health crisis arise."

Sovereignty and Global Health

He also pointed out that the American exit from the global health body and its pursuit of bilateral health agreements were upending structures already set up via the international health agency.

Mangwana gave as an example its Pathogen Access and Benefit Sharing framework designed to manage future global health emergencies.

"This mechanism is designed to ensure that when a country contributes its samples, the resulting advantages – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the funds to develop them."

The government's concerns regarding the US deal "must not be interpreted as hostility towards the US," he added.

"We encourage continued discussions with our US partners on how subsequent co-operation might be arranged in a way that respects the independence and interests of each country."

Medical Community Response

The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the official position, but suggested that negotiations must proceed since much of the country's Aids initiatives relied on external financing.

"If technical issues exist, including those involving information security or implementation frameworks, these can frequently be resolved through technical clarification and mutually agreed protections," the group commented.

The halted deal underscores the continuing debate between receiving much-needed foreign assistance and safeguarding a country's data in an ever more data-driven world.

By

Sarah Hunter

Voice coach and speech therapist with 15 years of experience helping professionals find their authentic voice.

CleanVoiceWorld

Type to search articles.